---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-26-003844"
form_type: "8-K"
ticker: null
cik: "0001289047"
company_name: "AI Technology Group Inc."
filed_at: "2026-06-12T21:05:43+00:00"
generated_at: "2026-06-12T21:11:02.108402+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# AI Tech Group amends merger agreement; extends closing to Dec 31, 2026, sets $50M minimum raise

## Summary
- Second amendment to merger with AVM Biotechnology and Biomed 360 details investment tranches: $1M (Tranche 1), $1.125M (partial Tranche 2), plus $500K monthly from June to Oct 2026 and $375K in Nov.
- Tranche 2 loans are convertible at $2.50/share with 10% simple interest; closing extended to Dec 31, 2026 (extendable to Mar 31, 2027).
- Tranche 3 requires at least $50M in gross proceeds before closing, at $5.00/share or higher, with a senior US exchange up‑listing.
- All other terms of the original Merger Agreement remain unchanged.

## SEC filing metadata
- accession: 0001477932-26-003844
- form_type: 8-K
- cik: 0001289047
- company_name: AI Technology Group Inc.
- filed_at: 2026-06-12T21:05:43+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1289047/000147793226003844/0001477932-26-003844-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1289047/000147793226003844/aipg_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-26-003844
- JSON: https://secwatch.observer/filing/0001477932-26-003844.json
- Plain text: https://secwatch.observer/filing/0001477932-26-003844.txt

## Key facts
- Material Agreements
  AI Technology Group Inc. entered into Agreement and Plan of Merger with AVM Biotechnology Inc. , a Nevada corporation (“AVM”), and Biomed 360 Solutions Corp. , a British Columbia corporation (“Biomed 360”) (effective 2025-09-15).
  - Action: entry
  - Agreement: merger
  - Counterparty: AVM Biotechnology Inc. , a Nevada corporation (“AVM”), and Biomed 360 Solutions Corp. , a British Columbia corporation (“Biomed 360”)
  - Effective: 2025-09-15
  source text: On September 15, 2025, AI Technology Group Inc. (the “Corporation”) filed, as Exhibit 10 to its registration statement filed on Form 10-12G, entered into a Agreement and Plan of Merger with AVM Biotechnology Inc. , a Nevada corporation (“AVM”), and Biomed 360 Solutions Corp. , a British Columbia corporation (“Biomed 360”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1289047/000147793226003844/0001477932-26-003844-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.